The FlexiGraft line of allografts are supported by pre-clinical and clinical publications which demonstrate the safety and efficacy of LifeNet Health allografts used in procedures such as ACL and PCL reconstruction.
Dr. Alan Hirahara
Orthopedic Surgeon / Specialist in Sports Medicine
The safety and quality of allograft bio-implants are critical to physicians and their patients. As a leading regenerative medicine company, LifeNet Health has developed a full suite of technologies to ensure these needs are met with every allograft we provide.
This patented and validated process renders allograft bio-implant tissue acellular; without compromising the biomechanical or desired biochemical properties of an allograft bio-impant surgical application.1
The goal of superior capsule reconstruction (SCR) with an acellular dermal allograft is to treat irreparable rotator cuff tears while minimizing donor-site morbidity. The technique is relatively new in the field and as such long-term data is recently coming to light. The article in review below summarizes the 2020 publication by Pashuck et. al. which reports clinical improvements in function and pain following SCR are maintained up to two years postoperative.
LifeNet Health provides high-quality allograft implants with the biomechanical specifications clincians need to perform successful sports medicine surgeries, such as superior capsule reconstruction, rotator cuff repair, and more. ArthroFlex decellularized dermal matrix implants are safe and clinically proven to provide reinforcement or covering for soft tissue repairs.
LifeNet Health is committed to providing valuable training for medical professionals. This program series offers new treatment perspectives, surgical techniques and methods to improve surgical skills and, ultimately patient outcomes using Dermacell® Acellular Dermall Matrix and/or Matrion™ Placental Membrane. These educational programs are specifically designed for podiatrists,residents, fellows, OR staff and practicing wound surgeons to facilitate further refinement of techniques utilizing these allograft tissues.
